Drug intelligence / Profile preview

N-{[6-(pentyloxy)naphthalen-2-yl]sulfonyl}-D-glutamic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

N-{[6-(pentyloxy)naphthalen-2-yl]sulfonyl}-D-glutamic acid is a synthetic small molecule and a derivative of D-glutamic acid, featuring a sulfonamide linkage to a substituted naphthalene ring. It is classified as an experimental compound and has not been approved for clinical use. The compound has been referenced in chemical databases such as DrugBank, ChEMBL, and PubChem but lacks detailed information on its mechanism of action or therapeutic indication. There are no reported clinical trials or approved indications for this molecule, suggesting it remains at the preclinical or early research stage[1][2][10].

Other names
N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACIDN-{[6-(Pentyloxy)-2-naphthyl]sulfonyl}-D-glutamic acid(2R)-2-[6-(pentyloxy)naphthalene-2-sulfonamido]pentanedioic acid
02

Targets

MurD (UDP-N-acetylmuramoylalanine--D-glutamate ligase)

Beyond the preview

Go deeper on N-{[6-(pentyloxy)naphthalen-2-yl]sulfonyl}-D-glutamic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-{[6-(pentyloxy)naphthalen-2-yl]sulfonyl}-D-glutamic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call